Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ammann

Showing results (181-190 of 182) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 182 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2018
<sup>18</sup>F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?Thomas W Georgi, Regine Kluge, Lars Kurch, et al.
The Lancet. Oncology|December 13, 2021
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trialChristine Mauz-Körholz, Judith Landman-Parker, Walentyna Balwierz, et al.
Pageof 19

Showing results (181-190 of 182) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 182 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2018
<sup>18</sup>F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?Thomas W Georgi, Regine Kluge, Lars Kurch, et al.
The Lancet. Oncology|December 13, 2021
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trialChristine Mauz-Körholz, Judith Landman-Parker, Walentyna Balwierz, et al.
Pageof 19